T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine
Diaz, P.S.; Smith, S.; Hunter, E.; Arvin, A.M.
The Journal of Immunology (1950) 142(2): 636-641
1989
ISSN/ISBN: 0022-1767 Accession: 078166574
Full Text Article emailed within 1 workday: $29.90
Related References
Diaz, P.S.; Smith, S.; Hunter, E.; Arvin, A.M. 1989: T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine Journal of Immunology 142(2): 636-641Tsolia, M.; Gershon, A.A.; Steinberg, S.P.; Gelb, L. 1990: Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group Journal of Pediatrics 116(2): 184-189
Baba, K.; Yabuuchi, H.; Takahashi, M.; Bogger, S.; Ogra, P.L. 1982: Protective efficacy of live attenuated varicella zoster virus vaccine against naturally acquired varicella zoster infection Pediatric Research 16(4 Part 2): 148A
Bernstein, H.H.; Rothstein, E.P.; Watson, B.M.; Reisinger, K.S.; Blatter, M.M.; Wellman, C.O.; Chartrand, S.A.; Cho, I.; Ngai, A.; White, C.J. 1993: Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine Pediatrics 92(6): 833-837
Tsolia, M.; Gershon, A.A.; Steiberg, S.P.; Gelb, L. 1990: Live attenuated varicella vaccine: Evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus The Journal of Pediatrics 116(2): 184-189
Vázquez, M. 2004: Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine Current Opinion in Pediatrics 16(1): 80-84
Chong, C.H.; Liu, C.-E.; Leong, Y.-Y.; Liao, S.-Y.; Lai, H.-W.; Lee, Y.-L. 2023: Seroprevalence of varicella-zoster virus antibody and immunogenicity of live attenuated varicella vaccine in healthcare workers in Taiwan Journal of Microbiology Immunology and Infection 56(2): 274-281
Kumagai, T.; Chiba, Y.; Fujiwara, M.; Hanazono, H.; Nakamura, S.; Chiba, S.; Nakao, T.; Takahashi, M. 1980: Humoral and cellular immune response to varicella-zoster virus in children inoculated with live attenuated varicella vaccine Biken Journal 23(3): 135-141
Hardy, I.; Gershon, A.A.; Steinberg, S.P.; LaRussa, P. 1991: The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group New England Journal of Medicine 325(22): 1545-1550
Terada, K.; Niizuma, T.; Ogita, S.; Kataoka, N. 2002: Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine Vaccine 20(31-32): 3638-3643
Diaz, P.S.; Smith, S.; Hunter, E.; Arvin, A.M. 1988: Immunity to whole varicella-zoster virus antigen and glycoproteins i and p170: relation to the immunizing regimen of live attenuated varicella vaccine Journal of Infectious Diseases 158(6): 1245-1252
Hayward, A.; Villanueba, E.; Cosyns, M.; Levin, M. 1992: Varicella-zoster virus (VZV)-specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccine Journal of Infectious Diseases 166(2): 260-264
Boudailliez, B. 1985: Prevention of varicella infection in renal transplanted children by previous immunization with a live attenuated varicella vaccine Transplantation Proceedingspart 1: 151-152
Gershon, A.A.; Levin, M.J.; Weinberg, A.; Song, L.-Y.; LaRussa, P.S.; Steinberg, S.P.; Bartlett, P.; Deveikis, A.; Batra, J.; Michalik, D.E.; Chen, T.; Keller, M.A.; Zangwill, K.; Mink, C.; Hayes, J.; Abrams, E.; Champion, S.; Frere, M.; Calo, D.; Borkowsky, W.; Kaul, A.; Chandwani, S.; Deygoo, S.; Rathore, M.H.; Alvarez, A.; Mirza, A.; Thomas, K.; Rutstein, R.M.; Douglas, S.D.; Vincent, C.A.; Puga, A.M.; Inman, A.; Talero, G.; McNamara, J.; Read, J.; Ortiz, A.; Wang, Y.; Bouquin, P.; Rosenblatt, H.M.; Kay, L.; Ferguson, E.; Chan, C.Y. 2009: A phase I-Ii study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella Pediatric Infectious Disease Journal 28(7): 653-655
Nader, S.; Bergen, R.; Sharp, M.; Arvin, A.M. 1995: Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine Journal of Infectious Diseases 171(1): 13-17
Hayward, A.R.; Buda, K.; Jones, M.; White, C.J.; Levin, M.J. 1996: Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine Viral Immunology 9(4): 241-245
Boda, D.; Bartyik, K.; Szüts, P.; Turi, S. 1986: Active immunization of children exposed to varicella infection in a hospital ward using live attenuated varicella vaccine given subcutaneously or intracutaneously Acta Paediatrica Hungarica 27(3): 247-252
Oitani, K. 1999: Expression of interleukin-2 receptor, CD25, on CD4 lymphocytes in response to varicella-zoster virus antigen among patients with malignancies immunized with live attenuated varicella vaccine Pediatrics International: Official Journal of the Japan Pediatric Society 41(1): 32-36
Law, B.J.; Group, M.O.T.e Winnipeg Research, I.A.bulatory Pediatrics 1994: Association between antibody response to live attenuated varicella zoster virus vaccine and subsequent varicella-like illness in Canadian children immunized during the second year of life Pediatric Research 37(4 Part 2): 110A
Dubey, V.; MacFadden, D. 2019: Disseminated varicella zoster virus infection after vaccination with a live attenuated vaccine Cmaj: Canadian Medical Association Journal 191(37): E1025-E1027